PCSK9 and fragile X syndrome: A previous report demonstrated that the typical correlation between total cholesterol and proprotein convertase subtilisin/kexin type 9 (PCSK9) levels was not observed in FXS individuals suggesting potentially altered PCSK9 function in FXS [4].